Neonatal acute respiratory distress with surfactant metabolism deficiency: genes and variants
Explore variant evidence for Neonatal acute respiratory distress with surfactant metabolism deficiency across 3 analyzed proteins (SFTPC, ABCA3, SFTPB). Linked ClinVar records include 8 pathogenic or likely pathogenic variants, 29 variants of uncertain significance and 15 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Neonatal acute respiratory distress with surfactant metabolism deficiency
SFTPC: Surfactant protein C
It contributes to pulmonary surfactant organization and is produced specifically by alveolar type II cells. Dominant pathogenic variants can cause interstitial lung disease across infancy and adulthood, often through protein misfolding and toxic cellular stress.
7 ClinVar pathogenic / likely pathogenic and 18 uncertain variants in SFTPC have source records linked to Neonatal acute respiratory distress with surfactant metabolism deficiency. Association strength is not clinical gene validity.
ABCA3: Phospholipid-transporting ATPase ABCA3
It transports phospholipids into lamellar bodies of alveolar type II cells, supporting pulmonary surfactant assembly and normal gas exchange. Biallelic loss-of-function variants can cause neonatal respiratory failure or childhood interstitial lung disease.
1 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in ABCA3 have source records linked to Neonatal acute respiratory distress with surfactant metabolism deficiency. Association strength is not clinical gene validity.
SFTPB: Pulmonary surfactant-associated protein B
It lowers surface tension and stabilizes pulmonary surfactant films during repeated breathing cycles, preventing alveolar collapse at end expiration. Biallelic loss-of-function variants cause severe neonatal surfactant dysfunction and respiratory failure.
0 ClinVar pathogenic / likely pathogenic and 24 uncertain variants in SFTPB have source records linked to Neonatal acute respiratory distress with surfactant metabolism deficiency. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Neonatal acute respiratory distress with surfactant metabolism deficiency
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| ABCA3 R208W | 208 | Pathogenic / likely pathogenic (★★) | |
| SFTPC I73T | 73 | Pathogenic / likely pathogenic (★★) | |
| SFTPC D105V | 105 | BRICHOS | Pathogenic / likely pathogenic (★) |
| SFTPC H64Q | 64 | Pathogenic / likely pathogenic (★) | |
| SFTPC E66K | 66 | Pathogenic / likely pathogenic | |
| SFTPC L188Q | 188 | BRICHOS | Pathogenic / likely pathogenic |
| SFTPC L194P | 194 | BRICHOS | Pathogenic / likely pathogenic |
| SFTPC A116D | 116 | BRICHOS | Pathogenic / likely pathogenic |
Which prediction tools work for Neonatal acute respiratory distress with surfactant metabolism deficiency
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 99 out of 100
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 95 out of 100
- MetaLR: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 91 out of 100
- phyloP: 82 out of 100
- ESM1b (LLR): 45 out of 100
Same protein, different disease
- Pulmonary alveolar proteinosis also has ClinVar records linked to SFTPC variants; they fall mostly in different places as the Neonatal acute respiratory distress with surfactant metabolism deficiency variants (4 pathogenic / likely pathogenic).
- Interstitial lung disease due to ABCA3 deficiency also has ClinVar records linked to ABCA3 variants; they fall mostly in different places as the Neonatal acute respiratory distress with surfactant metabolism deficiency variants (30 pathogenic / likely pathogenic).
- Pulmonary alveolar proteinosis also has ClinVar records linked to ABCA3 variants; they fall mostly in different places as the Neonatal acute respiratory distress with surfactant metabolism deficiency variants (12 pathogenic / likely pathogenic).
Diseases related to Neonatal acute respiratory distress with surfactant metabolism deficiency
- Pulmonary alveolar proteinosis, also linked to ABCA3, SFTPB and SFTPC
- Interstitial lung disease, also linked to ABCA3 and SFTPC
- Loeys-Dietz syndrome, also linked to ABCA3
- Interstitial lung disease due to ABCA3 deficiency, also linked to ABCA3
- Idiopathic pulmonary fibrosis, also linked to SFTPC
Frequently asked questions
Which genes have records linked to Neonatal acute respiratory distress with surfactant metabolism deficiency?
This view contains 3 analyzed proteins: SFTPC, ABCA3, SFTPB. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 8 pathogenic or likely pathogenic variants, 29 variants of uncertain significance and 15 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 119 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center